Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/66/06/52/660652a6-861a-ce6f-d79f-217319c9629c/mza_15907580138243686210.jpg/600x600bb.jpg
Clinical Journal of the American Society of Nephrology (CJASN)
American Society of Nephrology
195 episodes
2 weeks ago
Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.
Show more...
Medicine
Health & Fitness,
Science
RSS
All content for Clinical Journal of the American Society of Nephrology (CJASN) is the property of American Society of Nephrology and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.
Show more...
Medicine
Health & Fitness,
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/66/06/52/660652a6-861a-ce6f-d79f-217319c9629c/mza_15907580138243686210.jpg/600x600bb.jpg
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management
Clinical Journal of the American Society of Nephrology (CJASN)
17 minutes 49 seconds
1 year ago
Editors Choice Articles: SGLT2 inhibitors in frailty, multimorbidity and polypharmacy; SGLT2 inhibitors and cardiovascular death; and mobile health technology in CKD management
CJASN editors highlight three articles centered on the theme of CKD, including articles on SGLT2 inhibitors in CKD patients; SGLT2 inhibitors and cardiovascular death in CKD; and smartphone intervention for lifestyle and hypertension management in CKD.
Clinical Journal of the American Society of Nephrology (CJASN)
Clinical Journal of the American Society of Nephrology (CJASN) publishes high quality research relevant to clinical nephrology. Now one of the most widely-read and referenced kidney journals, physicians read CJASN to learn about the most important advances in clinical and translational research in nephrology.